237 related articles for article (PubMed ID: 34301864)
1. Cell membrane-camouflaged liposomes for tumor cell-selective glycans engineering and imaging in vivo.
Liu Z; Wang F; Liu X; Sang Y; Zhang L; Ren J; Qu X
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301864
[TBL] [Abstract][Full Text] [Related]
2. A Nature-Inspired Metal-Organic Framework Discriminator for Differential Diagnosis of Cancer Cell Subtypes.
Liu Z; Zhang L; Cui T; Ma M; Ren J; Qu X
Angew Chem Int Ed Engl; 2021 Jul; 60(28):15436-15444. PubMed ID: 33960090
[TBL] [Abstract][Full Text] [Related]
3. Leutusome: A Biomimetic Nanoplatform Integrating Plasma Membrane Components of Leukocytes and Tumor Cells for Remarkably Enhanced Solid Tumor Homing.
He H; Guo C; Wang J; Korzun WJ; Wang XY; Ghosh S; Yang H
Nano Lett; 2018 Oct; 18(10):6164-6174. PubMed ID: 30207473
[TBL] [Abstract][Full Text] [Related]
4. Cell-selective metabolic glycan labeling based on ligand-targeted liposomes.
Xie R; Hong S; Feng L; Rong J; Chen X
J Am Chem Soc; 2012 Jun; 134(24):9914-7. PubMed ID: 22646989
[TBL] [Abstract][Full Text] [Related]
5. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis.
Qiu X; Li Z; Han X; Zhen L; Luo C; Liu M; Yu K; Ren Y
Theranostics; 2019; 9(9):2618-2636. PubMed ID: 31131057
[TBL] [Abstract][Full Text] [Related]
7. Facile preparation of well-defined hydrophilic core-shell upconversion nanoparticles for selective cell membrane glycan labeling and cancer cell imaging.
Zhang W; Peng B; Tian F; Qin W; Qian X
Anal Chem; 2014 Jan; 86(1):482-9. PubMed ID: 24294983
[TBL] [Abstract][Full Text] [Related]
8. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics.
Zhang M; Cheng S; Jin Y; Zhang N; Wang Y
Clin Transl Med; 2021 Feb; 11(2):e292. PubMed ID: 33635002
[TBL] [Abstract][Full Text] [Related]
9. Engineering cancer cell membrane-camouflaged metal complex for efficient targeting therapy of breast cancer.
Li X; Yu Y; Chen Q; Lin J; Zhu X; Liu X; He L; Chen T; He W
J Nanobiotechnology; 2022 Sep; 20(1):401. PubMed ID: 36064356
[TBL] [Abstract][Full Text] [Related]
10. Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer.
Cao H; Dan Z; He X; Zhang Z; Yu H; Yin Q; Li Y
ACS Nano; 2016 Aug; 10(8):7738-48. PubMed ID: 27454827
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic theranostic strategy for anti-metastasis therapy of breast cancer via the macrophage membrane camouflaged superparticles.
Liang B; Deng T; Li J; Ouyang X; Na W; Deng D
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111097. PubMed ID: 32600701
[TBL] [Abstract][Full Text] [Related]
12. Engineering Biomimetic Platesomes for pH-Responsive Drug Delivery and Enhanced Antitumor Activity.
Liu G; Zhao X; Zhang Y; Xu J; Xu J; Li Y; Min H; Shi J; Zhao Y; Wei J; Wang J; Nie G
Adv Mater; 2019 Aug; 31(32):e1900795. PubMed ID: 31222856
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles target early-stage breast cancer metastasis in vivo.
Goldman E; Zinger A; da Silva D; Yaari Z; Kajal A; Vardi-Oknin D; Goldfeder M; Schroeder JE; Shainsky-Roitman J; Hershkovitz D; Schroeder A
Nanotechnology; 2017 Oct; 28(43):43LT01. PubMed ID: 28872058
[TBL] [Abstract][Full Text] [Related]
14. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
[TBL] [Abstract][Full Text] [Related]
15. Liposome-Assisted Metabolic Glycan Labeling With Cell and Tissue Selectivity.
Du Y; Xie R; Sun Y; Fan X; Chen X
Methods Enzymol; 2018; 598():321-353. PubMed ID: 29306441
[TBL] [Abstract][Full Text] [Related]
16. Cancer Cell Membrane-Biomimetic Nanoplatform for Enhanced Sonodynamic Therapy on Breast Cancer via Autophagy Regulation Strategy.
Feng Q; Yang X; Hao Y; Wang N; Feng X; Hou L; Zhang Z
ACS Appl Mater Interfaces; 2019 Sep; 11(36):32729-32738. PubMed ID: 31415145
[TBL] [Abstract][Full Text] [Related]
17. A PEG-assisted membrane coating to prepare biomimetic mesoporous silicon for PET/CT imaging of triple-negative breast cancer.
Wen H; MartÃnez MG; Happonen E; Qian J; Vallejo VG; Mendazona HJ; Jokivarsi K; Scaravilli M; Latonen L; Llop J; Lehto VP; Xu W
Int J Pharm; 2024 Mar; 652():123764. PubMed ID: 38176479
[TBL] [Abstract][Full Text] [Related]
18. Biomimetic Decoy Inhibits Tumor Growth and Lung Metastasis by Reversing the Drawbacks of Sonodynamic Therapy.
Zhao H; Zhao B; Li L; Ding K; Xiao H; Zheng C; Sun L; Zhang Z; Wang L
Adv Healthc Mater; 2020 Jan; 9(1):e1901335. PubMed ID: 31762228
[TBL] [Abstract][Full Text] [Related]
19. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis.
Jing M; Bi XJ; Yao XM; Cai F; Liu JJ; Fu M; Kong L; Liu XZ; Zhang L; He SY; Jia LQ; Li XT
Drug Dev Ind Pharm; 2020 Apr; 46(4):621-634. PubMed ID: 32162988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
